Information Provided By:
Fly News Breaks for May 8, 2018
EGLT
May 8, 2018 | 13:58 EDT
Cantor Fitzgerald analyst Louise Chen downgraded Egalet to Neutral from Overweight and cut her price target for the shares to $1.50 from $3.50. Following the company's Q1 results, the analyst prefers moving to the sidelines pending more visibility on the sales trajectory and durability of its products. Chen, however, thinks Egalet's non-opioid pain treatment Sprix nasal spray could drive "significant upside" to her new forecasts.
News For EGLT From the Last 2 Days
There are no results for your query EGLT